JP2018521995A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018521995A5 JP2018521995A5 JP2017566402A JP2017566402A JP2018521995A5 JP 2018521995 A5 JP2018521995 A5 JP 2018521995A5 JP 2017566402 A JP2017566402 A JP 2017566402A JP 2017566402 A JP2017566402 A JP 2017566402A JP 2018521995 A5 JP2018521995 A5 JP 2018521995A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- drinking water
- medicinal
- obtainable
- isoxazoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 22
- 239000003651 drinking water Substances 0.000 claims 20
- 235000020188 drinking water Nutrition 0.000 claims 20
- -1 methoxyethyl Chemical group 0.000 claims 20
- 238000000034 method Methods 0.000 claims 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 8
- 241001465754 Metazoa Species 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 7
- 230000003071 parasitic effect Effects 0.000 claims 7
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 claims 6
- 244000045947 parasite Species 0.000 claims 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 6
- 229930003427 Vitamin E Natural products 0.000 claims 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 229940046009 vitamin E Drugs 0.000 claims 4
- 239000011709 vitamin E Substances 0.000 claims 4
- 235000019165 vitamin E Nutrition 0.000 claims 4
- 238000007865 diluting Methods 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- 241000238421 Arthropoda Species 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 claims 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000004970 halomethyl group Chemical group 0.000 claims 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical group Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000005767 propoxymethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])[#8]C([H])([H])* 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
- FLEFKKUZMDEUIP-QFIPXVFZSA-N 1-[6-[(5s)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@](ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 FLEFKKUZMDEUIP-QFIPXVFZSA-N 0.000 claims 1
- HDKWFBCPLKNOCK-SFHVURJKSA-N 3-methyl-n-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-5-[(5s)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)NCC(=O)NCC(F)(F)F)=C(C)C=C1C1=NO[C@](C(F)(F)F)(C=2C=C(Cl)C(Cl)=C(Cl)C=2)C1 HDKWFBCPLKNOCK-SFHVURJKSA-N 0.000 claims 1
- OXDDDHGGRFRLEE-UHFFFAOYSA-N 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]-n-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide Chemical compound C12=CC=CC=C2C(C(=O)NCC(=O)NCC(F)(F)F)=CC=C1C(C1)=NOC1(C(F)(F)F)C1=CC(Cl)=CC(C(F)(F)F)=C1 OXDDDHGGRFRLEE-UHFFFAOYSA-N 0.000 claims 1
- 239000004155 Chlorine dioxide Substances 0.000 claims 1
- 206010061217 Infestation Diseases 0.000 claims 1
- 229960000982 afoxolaner Drugs 0.000 claims 1
- 125000004686 alkyl sulfanyl alkyl group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 229940087168 alpha tocopherol Drugs 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 235000019398 chlorine dioxide Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000006184 cosolvent Substances 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 claims 1
- MLBZKOGAMRTSKP-UHFFFAOYSA-N fluralaner Chemical compound C1=C(C(=O)NCC(=O)NCC(F)(F)F)C(C)=CC(C=2CC(ON=2)(C=2C=C(Cl)C=C(Cl)C=2)C(F)(F)F)=C1 MLBZKOGAMRTSKP-UHFFFAOYSA-N 0.000 claims 1
- 229960004498 fluralaner Drugs 0.000 claims 1
- 229920005555 halobutyl Polymers 0.000 claims 1
- 125000004968 halobutyl group Chemical group 0.000 claims 1
- 125000004969 haloethyl group Chemical group 0.000 claims 1
- 229950002303 lotilaner Drugs 0.000 claims 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 1
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 125000004673 propylcarbonyl group Chemical group 0.000 claims 1
- 238000011012 sanitization Methods 0.000 claims 1
- 229960005393 sarolaner Drugs 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 229960000984 tocofersolan Drugs 0.000 claims 1
- 239000002076 α-tocopherol Substances 0.000 claims 1
- 235000004835 α-tocopherol Nutrition 0.000 claims 1
- 125000001020 α-tocopherol group Chemical group 0.000 claims 1
- 0 *Cc1ccccn1 Chemical compound *Cc1ccccn1 0.000 description 2
- XNTFQMKXUFFUQO-UHFFFAOYSA-N C[n]1nccc1CN Chemical compound C[n]1nccc1CN XNTFQMKXUFFUQO-UHFFFAOYSA-N 0.000 description 1
- HRVLXTZHPZXHTR-UHFFFAOYSA-N NC1(CC1)c1ccccn1 Chemical compound NC1(CC1)c1ccccn1 HRVLXTZHPZXHTR-UHFFFAOYSA-N 0.000 description 1
- FVLAYJRLBLHIPV-UHFFFAOYSA-N Nc1cncnc1 Chemical compound Nc1cncnc1 FVLAYJRLBLHIPV-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15173454 | 2015-06-23 | ||
| EP15173454.8 | 2015-06-23 | ||
| PCT/EP2016/064449 WO2016207234A1 (en) | 2015-06-23 | 2016-06-22 | Isoxazoline solution containing vitamin e for use with sanitized drinking water |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018521995A JP2018521995A (ja) | 2018-08-09 |
| JP2018521995A5 true JP2018521995A5 (enExample) | 2019-07-25 |
| JP6933983B2 JP6933983B2 (ja) | 2021-09-08 |
Family
ID=53488226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017566402A Active JP6933983B2 (ja) | 2015-06-23 | 2016-06-22 | 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20180169073A1 (enExample) |
| EP (1) | EP3313400B1 (enExample) |
| JP (1) | JP6933983B2 (enExample) |
| CN (1) | CN107750159B (enExample) |
| BR (1) | BR112017027855B1 (enExample) |
| ES (1) | ES2920394T3 (enExample) |
| HU (1) | HUE059228T2 (enExample) |
| MX (1) | MX383746B (enExample) |
| PL (1) | PL3313400T3 (enExample) |
| WO (1) | WO2016207234A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016022066A1 (en) | 2014-08-04 | 2016-02-11 | Jerry Tan Eye Surgery Pte Ltd | Pharmaceutical compositions for demodex related blepharitis and eyelid crusting |
| KR102668200B1 (ko) * | 2015-10-28 | 2024-05-23 | 주식회사유한양행 | 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물 |
| UY40429A (es) | 2016-02-24 | 2023-10-13 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
| AU2018385766B2 (en) | 2017-12-15 | 2022-12-01 | Tarsus Pharmaceuticals, Inc. | Isoxazoline parasiticide formulations and methods for treating blepharitis |
| US12502377B2 (en) | 2019-04-04 | 2025-12-23 | Tarsus Pharmaceuticals, Inc. | Method of eradicating ticks that attach to humans using lotilaner formulations |
| CA3164924A1 (en) | 2019-12-18 | 2021-06-24 | Elanco Tiergesundheit Ag | Isoxazoline derivatives as pesticides |
| AU2021311722A1 (en) | 2020-07-24 | 2023-02-02 | Elanco Us Inc. | Process for making an isoxazoline compound and intermediate thereof |
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| KR20230162001A (ko) * | 2021-03-11 | 2023-11-28 | 인 더 보울 애니멀 헬스, 인크. | 갯과에서 진드기 감염을 방제하기 위한 경구용 갯과 사료 및 방법 |
| CN114306231B (zh) * | 2021-12-29 | 2023-03-24 | 天津市中升挑战生物科技有限公司 | 一种氟雷拉纳杀虫剂及其制备方法和应用 |
| CN115266988A (zh) * | 2022-08-01 | 2022-11-01 | 江苏慧聚药业股份有限公司 | 一种氟雷拉钠有关物质的检测方法 |
| CN117064851B (zh) * | 2023-09-20 | 2026-02-17 | 中国农业大学 | 一种异噁唑啉类驱虫药制剂的制备方法 |
| CN118477040B (zh) * | 2024-04-11 | 2025-02-25 | 河北威远药业有限公司 | 一种氟雷拉纳溶液的制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962488A (en) * | 1998-04-08 | 1999-10-05 | Roberts Laboratories, Inc. | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives |
| ATE473944T1 (de) * | 2000-06-27 | 2010-07-15 | Procter & Gamble | Mittel zur wasserbehandlung |
| US20050005868A1 (en) * | 2003-07-11 | 2005-01-13 | Shepard Allan T. | Animal drinking water production |
| AU2005219788B2 (en) | 2004-03-05 | 2010-06-03 | Nissan Chemical Corporation | Isoxazoline-substituted benzamide compound and noxious organism control agent |
| TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
| JP2007319124A (ja) * | 2006-06-02 | 2007-12-13 | Nippon Tablet Kk | 健康食品 |
| US8372867B2 (en) | 2007-04-10 | 2013-02-12 | Bayer Cropscience Ag | Insecticidal aryl isoxazoline derivatives |
| TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
| ES2549731T3 (es) | 2007-06-27 | 2015-11-02 | E. I. Du Pont De Nemours And Company | Método para el control de plagas en animales |
| US20090024541A1 (en) * | 2007-07-20 | 2009-01-22 | Gary Kremen | Power purchase methods, agreements and financial instruments for tax-advantaged financing residential renewable energy equipment |
| TWI556741B (zh) * | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
| TWI411395B (zh) | 2007-12-24 | 2013-10-11 | Syngenta Participations Ag | 殺蟲化合物 |
| CN102088856B (zh) * | 2008-07-09 | 2015-11-25 | 巴斯夫欧洲公司 | 包含异*唑啉化合物的杀虫活性混合物i |
| US7951404B2 (en) | 2008-07-11 | 2011-05-31 | Sanosil Ag | Concentrate for preparing a disinfectant and methods for its preparation and use |
| ES2442342T3 (es) | 2008-12-18 | 2014-02-11 | Novartis Ag | Derivados de las isoxazolinas y su uso como pesticida |
| CA2747354C (en) | 2008-12-19 | 2016-12-06 | Novartis Ag | Isoxazoline derivatives and their use as pesticide |
| EP3078664B1 (en) | 2009-12-17 | 2019-02-20 | Merial Inc. | Antiparasitic dihydroazole compositions |
| JP2013518084A (ja) * | 2010-02-01 | 2013-05-20 | ビーエーエスエフ ソシエタス・ヨーロピア | 有害動物を駆除するための置換されたケトン性イソオキサゾリン化合物および誘導体 |
| MX2012011549A (es) | 2010-04-08 | 2013-01-29 | Ah Usa 42 Llc | Derivados de 3,5-difenil-isoxazolina sustituida como insecticidas y acaricidas. |
| WO2012155352A1 (en) | 2011-05-19 | 2012-11-22 | Eli Lilly And Company | Dihydroisoxazole compounds, parasiticidal uses and formulations thereof |
| KR20140054302A (ko) | 2011-08-25 | 2014-05-08 | 신젠타 파티서페이션즈 아게 | 살곤충 화합물로서의 이속사졸린 유도체 |
| WO2013026695A1 (en) | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Isoxazoline derivatives as insecticidal compounds |
| PL3172964T3 (pl) * | 2011-09-12 | 2021-03-08 | Boehringer Ingelheim Animal Health USA Inc. | Kompozycje przeciwpasożytniczne zawierające izoksazolinową substancję czynną, sposób i ich zastosowania |
| CA2924537C (en) | 2013-09-30 | 2018-01-16 | Todd P. Foster | Long-acting spiro-isoxazoline formulations |
| US9371293B2 (en) | 2013-10-25 | 2016-06-21 | Sumitomo Chemical Company, Limited | Isoxazoline compound composition |
| DK3063144T3 (da) | 2013-11-01 | 2021-10-25 | Boehringer Ingelheim Animal Health Usa Inc | Antiparasitære og pesticid-isoxazolinforbindelser |
| WO2015086551A1 (en) * | 2013-12-10 | 2015-06-18 | Intervet International B.V. | Antiparasitic use of isoxazoline compounds |
| PT3082806T (pt) * | 2013-12-20 | 2021-06-04 | Intervet Int Bv | Utilização de derivados de isoxazolina para o tratamento ou a prevenção de infestações de artrópodes em aves |
| RU2688919C1 (ru) * | 2013-12-20 | 2019-05-23 | Интервет Интернэшнл Б.В. | Изоксазолиновые композиции и их применение в провилактике или лечении паразитарных инвазий животных |
| US20170354593A1 (en) * | 2014-11-03 | 2017-12-14 | Zoetis Services Llc | Palatable chewable veterinary composition |
-
2016
- 2016-06-22 HU HUE16733385A patent/HUE059228T2/hu unknown
- 2016-06-22 EP EP16733385.5A patent/EP3313400B1/en active Active
- 2016-06-22 BR BR112017027855-3A patent/BR112017027855B1/pt active IP Right Grant
- 2016-06-22 JP JP2017566402A patent/JP6933983B2/ja active Active
- 2016-06-22 PL PL16733385.5T patent/PL3313400T3/pl unknown
- 2016-06-22 CN CN201680036814.8A patent/CN107750159B/zh active Active
- 2016-06-22 ES ES16733385T patent/ES2920394T3/es active Active
- 2016-06-22 MX MX2017016671A patent/MX383746B/es unknown
- 2016-06-22 WO PCT/EP2016/064449 patent/WO2016207234A1/en not_active Ceased
- 2016-06-22 US US15/735,252 patent/US20180169073A1/en not_active Abandoned
-
2019
- 2019-07-26 US US16/523,780 patent/US11179372B2/en active Active
-
2021
- 2021-07-30 US US17/390,258 patent/US11878006B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018521995A5 (enExample) | ||
| JP2014504586A5 (enExample) | ||
| JP2014506249A5 (enExample) | ||
| RU2016129474A (ru) | Изоксазолиновые композиции | |
| JP2016540028A5 (enExample) | ||
| JP2017538767A5 (enExample) | ||
| RU2013135280A (ru) | Состав изоксазолина для местного и наружного применения | |
| JP2013510124A5 (enExample) | ||
| RU2015123737A (ru) | Производство полупластичных фармацевтических препаратов | |
| JP2013545785A5 (enExample) | ||
| JP2005508967A5 (enExample) | ||
| PE20190328A1 (es) | Compuestos de carfilzomib pegilados | |
| RU2013135415A (ru) | Изоксазолиновый состав, содержащий гликофурол для наружного и местного применения | |
| SI2978752T1 (en) | 6- (5-Hydroxy-1H-pyrazol-1-yl) nicotinamide derivatives and their use as inhibitors of PHD | |
| JO3430B1 (ar) | مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
| RU2010143857A (ru) | Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибриторов parp и ингибиторов полимеризации тубулина | |
| EP2987791A4 (en) | Novel 3- (4- (benzyloxy) phenyl) hexadecanoic acid derivative, process for the preparation thereof, and pharmaceutical composition for the prevention and treatment of metabolic disorders, therefore, as an active ingredient | |
| IL274065B2 (en) | Injectable isoxazoline pharmaceutical compounds and their antiparasitic use | |
| RU2016123144A (ru) | Сложноэфирное хиральное соединение (n-замещенный имидазол)-карбоновой кислоты, содержащее простую эфирную боковую цепь, его получение и применение | |
| RU2015150120A (ru) | Соединение дикарбоновой кислоты | |
| AR081821A1 (es) | Antranilamidas sustituidas con triazol como plaguicidas | |
| AR037350A1 (es) | Derivados de piperidina, proceso para preparar estos compuestos, composicion farmaceutica, y uso de estos compuestos para la manufactura de un medicamento util para el tratamiento de una enfermedad mediada por ccr5 (tal como artritis reumatoidea) | |
| RU2481344C2 (ru) | Замещенные (оксазолидинон-5-ил-метил)-2-тиофен-карбоксамиды и их применение в сфере свертывания крови | |
| EA201590474A1 (ru) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ КОМПОЗИТНЫХ КАПСУЛ, ВКЛЮЧАЮЩИХ ИРБЕСАРТАН И ИНГИБИТОР ГМГ-КоА РЕДУКТАЗЫ | |
| NZ722727A (en) | 1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof |